Kidney cancer

Active Research Protocols

  1. 00-C-0121 – A Phase I Investigation of IL-12/Pulse IL-2 in Adults with Advanced Solid Tumors
  2. 02-C-0159 – The Birt Hogg-Dube Syndrome: Identification of the Disease Gene and Characterization of the Predisposition of Renal Cancer
  3. 03-C-0066 – Hereditary Leiomyomatosis Renal Cell Cancer (HLRCC): Identification of the Disease Gene and Characterization of the Predisposition to Renal Cancer
  4. 04-C-0238 – A Phase II Study of 17-Allylamino-17-Demethoxygeldanamycin in Patients with Von Hippel Lindau Disease and Renal Tumors
  5. 06-C-0115 – Studies on the Mechanism of Action of High-Dose IL-2 in Metastatic Melanoma and Renal Cell Cancer
  6. 07-C-0121 – A Phase 2 Study of the C-Met RTK Inhibitor Foretinib (Formerly GSK 1363089) in Subjects with Papillary Renal-Cell Carcinoma (PRC)
  7. 08-C-0088 – Low Intensity Allogeneic Hematopoietic Stem Cell Transplantation Therapy of Metastatic Renal Cell Carcinoma using Early and Multiple Donor Lymphocyte Infusions Consisting of Sirolimus-Generated Donor Th2 Cells
  8. 08-C-0121 – Phase II Study of Metastatic Cancer that Expresses NY-ESO-1 Using Lymphodepleting Conditioning Followed by Infusion of Anti-NY ESO-1 TCR-Gene Engineered Lymphocytes
  9. 08-H-0186 – Safety and the Anti-Tumor Effects of Escalating Doses of Adoptively Infused Ex Vivo Expanded Autologous Natural Killer (NK) Cells Against Metastatic Cancers or Hematological Malignancies Sensitized to NK√?TRAIL Cytotoxicity with Bortezomib
  10. 09-C-0072 – Randomized Pilot Study for the Treatment of Cutaneous Leiomyomas with Botulinum Toxin
  11. 09-C-0080 – A Phase 2, Open-label, Proof-of-Concept Study to Assess the Ability to Detect Tumours and Angiogenesis via the Expression of Alpha v Beta 3 Integrin Receptors by (18F)AH-111585 PET Imaging
  12. 09-C-0111 – A Phase 1, Dose Escalation Study of the Safety, Tolerability and Pharmacokinetics of Intravenous Dimethane Sulfonate (DMS612, NSC 281612) in Advanced Malignancies
  13. 10-C-0021 – A Phase I Study of Intravenous Recombinant Human IL-15(rhIL-15) in Adults with Metastatic Malignant Melanoma and Metastatic Renal Cell Cancer
  14. 10-C-0078 – A Pilot Study of F-18 Paclitaxel (FPAC) PET for Evaluating Drug Delivery of Solid Tumors in Breast, Lung, Renal, and Adrenal Cancers
  15. 10-C-0086 – Comprehensive Omics Analysis of Pediatric Solid Tumors and Establishment of a Repository for Related Biological Studies
  16. 10-C-0113 – A Pilot Study of EZN-2968, an Antisense Oligonucleotide Inhibitor of HIF-1alpha, in Adults with Advance Solid Tumors
  17. 10-C-0114 – A Phase II Study of Bevacizumab and Erlotinib in Subjects with Advanced Hereditary Leiomyomatosis and Renal Cell Cancer (HLRCC) or Sporadic Papillary Renal Cell Cancer
  18. 12-C-0166 – A Phase II Study of Cabazitaxel in Patients with Urothelial Carcinoma Who Have Disease Progression Following Platinum-Based Chemotherapy
  19. 89-C-0086 – Clinical Manifestations and Molecular Bases of Heritable Urologic Malignant Disorders
  20. 97-C-0147 – Collection of Serum and Tissue Samples from Patients with Biopsy-Proved or Suspected Malignant Disease
  21. 97-H-0196 – A Phase II Study of HLA-Matched Peripheral Blood Stem Cell Transplantation for Metastatic Renal Cell Carcinoma as Adoptive Allogeneic Immunotherapy
  22. 99-C-0053 – Von Hippel-Lindau (VHL) Disease Genetic Epidemiology Study
NOTE: PDF documents require the free
Adobe Reader.
This page was last updated: January 24, 2014